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Sleep-Disordered Breathing in Alcoholics 
Michael S. Aldrich, Kirk J .  Brower, and Janette M. Hall 
Sleep apnea and related disorders contribute to disturbed sleep in 
abstinent alcoholics. In an earlier report from our group, sleep- 
disordered breathing was common and increased with age in a co- 
hort of 75 abstinent alcoholics. We now report an extension of the 
previous work that includes studies of an additional 103 abstinent 
alcoholics undergoing treatment for alcoholism (total sample = 188) 
and a comparison group of 87 normal subjects. The presence and 
severity of sleep-disordered breathing was assessed with polysom- 
nography. Among the alcoholics, sleep-disordered breathing (de- 
fined as 10 or more apneas plus hypopneas per hour of sleep) was 
present in 3% of 91 subjects under age 40,17% of 83 subjects age 40 
to 59, and 50% of 14 subjects age 60 or over. Subjects with sleep- 
disordered breathing were more likely to be male and had more 
severe sleep disruption and nocturnal hypoxemia and more com- 
plaints related to daytime sleepiness than subjects without sleep- 
disordered breathing. In a multiple linear regression analysis, age 
and body mass index were significant predictors of the presence of 
sleep-disordered breathing, whereas smoking history and duration 
of heavy drinking were not predictors after controlling for the effects 
of age and body mass index. Our findings suggest that sleep- 
disordered breathing contributes significantly to sleep disturbance 
in a substantial proportion of older alcoholics and that symptomatic 
sleep-disordered breathing increases with age in alcoholics. Sleep- 
disordered breathing, when combined with existing cardiovascular 
risk factors, may contribute to adverse health consequences in al- 
coholics. 
Key Words: Alcoholism, Sleep, Sleep Disorders, Sleep-Disordered 
Breathing, Obstructive Sleep Apnea. 
ILE THE association of alcohol use with snoring is 
cally of no importance before the discovery of obstructive 
sleep apnea (OSA). With accumulating evidence that OSA 
has significant health consequences, the effects of alcohol 
on breathing assume added significance. 
OSA is characterized by periods of airway narrowing or 
closure during sleep. During sleep, the upper airway dilator 
muscles that maintain airway patency become less active, 
the diameter of the airway decreases, and the resistance to 
breathing increases. The increased force generated by in- 
w well known, snoring was generally considered clini- 
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spiratory muscles to overcome the higher resistance can 
lead to collapse of the pharyngeal airway. Once the airway 
closes, a partial awakening is usually required to activate 
the upper airway dilator muscles and reopen the airway. 
The repeated arousals and awakenings lead to sleep dis- 
ruption and daytime sleepiness. With severe OSA, apneas 
followed by arousals occur virtually every minute of the 
night. 
Alcohol relaxes upper airway dilator muscles, which 
leads to upper airway narrowing, increased resistance to 
breathing, increased airflow velocity, and increased snor- 
ing. Evening alcohol consumption causes increased airway 
resistance during wakefulness and during the first 2 hr of 
sleep, when the blood alcohol concentration is high.'-3 The 
increased airway resistance and associated increased in- 
spiratory effort may lead to airway occlusion in persons 
who do not usually have obstructive apneas. Persons who 
snore are more likely to develop obstructive apneas after 
alcohol consumption, because their pharyngeal airways 
tend to be smaller than those of nonsnorers. Similarly, men, 
who tend to have narrower pharyngeal airways than 
women, appear to be more susceptible to the effects of 
alcohol on Furthermore, in persons with OSA, 
alcohol can increase the frequency and duration of apneas 
and the severity of associated hypoxemia.6-'0 
The effects of alcohol on breathing during sleep suggest 
that sleep-disordered breathing (SDB) may be an impor- 
tant contributor to sleep complaints and sleep disruption in 
alcoholics. Previous studies showed that apnea was com- 
mon, especially in older male alcoholics. For example, Tan 
et al." found that abstinent male alcoholics had increased 
numbers of central and obstructive apneas and hypopneas, 
compared with controls, whereas Mamdani and cowork- 
found that 31% of 80 abstinent alcoholic men had an 
apnea-hypopnea index (AHI) >5. In an earlier report on a 
cohort of 75 abstinent alcoholics, our group found SDB 
(AH1 > 10) in 25% of males between ages 40 to 59, and 
75% of males over age 60.13 Nocturnal hypoxemia, ob- 
served in some studies of alcoholics, may be due in part to 
smoking; but, in one study, severity of hypoxemia corre- 
lated better with duration of alcohol use than with smoking 
history or Thus, sleep apnea probably contributed 
to nocturnal hypoxemia in these subjects, although full 
polysomnography was not performed. 
The exacerbation of sleep apnea by alcohol consumed 
within a few hours of sleep o n ~ e t , ~ , ~ , ~ , ~ , "  and the associa- 
tion of sleep apnea with cardiovascular morbidity and mor- 
ta l i t~"- '~  suggests that the occurrence of sleep apnea in 
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clinical problem. 
Excessive daytime sleepiness, loud snoring, and periods 
of apnea witnessed by the bed partner are the usual pre- 
senting symptoms of OSA. Reliable demographic predic- 
tors include high body mass index (BMI), older age, and 
male gender.20 The prevalence of OSA is -2% in adult 
women and 4% in adult men.21 
Clinical assessment of symptoms suggestive of OSA in- 
cludes evaluation of clinical features, responses to one or 
more sleep related questionnaires, and polysomnography. 
Schafer et a1.22 reported a method for screening symptom- 
atic patients using home-based monitoring, which yielded 
high sensitivity (94%), but low specificity (41%), when used 
alone. Accuracy improved (specificity of 92%) when home 
monitoring was used in combination with clinical features 
and questionnaire responses. Pouliot et al.23 assessed use of 
the Epworth Sleepiness Scale (ESS), a measure of excessive 
daytime sleepiness, alone and in combination with clinical 
data (BMI and history of observed apneas) to identify 
patients with suspected OSA who were likely to have less 
severe apnea [apnea index (AI) < 201. The ESS score alone 
had poor predictive value, with 40% of the patients iden- 
tified as lower risk (AI < 20) being misclassified (AI > 20 
on polysomnography). ESS combined with BMI improved 
the accuracy, with only 6% falsely classified as lower risk; 
but, the percentage of patients misclassified as higher risk 
was increased. Douglass et al.24 reported adequate valida- 
tion, and a test-retest reliability of 0.84 for the Apnea Scale 
of the Sleep Disorders Questionnaire (SDQ) used in the 
study presented herein. However, no independent studies 
on use of the SDQ Apnea Scale for identification of sus- 
pected OSA have been published. Simplified diagnostic 
procedures based on questionnaire responses and clinical 
presentation may eventually allow a broader range of pa- 
tients to be evaluated for OSA. Currently, however, sim- 
plified diagnostic procedures have not proven to be valid or 
reliable. Definitive diagnosis of OSA still requires full poly- 
somnography. 
which includes studies of an additional 113 abstinent alco- 
holics undergoing treatment for alcoholism (total sample = 
188) and a comparison group of 87 normal subjects. 
We report herein an extension of our previous 
METHODS 
Subjects were recruited from alcohol treatment programs at the Uni- 
versity of Michigan Hospitals, the Ann Arbor Veterans Administration 
Medical Center, and the Chelsea Arbor Treatment Center. All subjects 
had alcoholism diagnosed by clinical evaluation and Diagnostic Interview 
Schedule2’ and were undergoing treatment for alcoholism. Mean years of 
heavy drinking was 11.8 2 9.3 (mean 2 SD). Potential subjects were 
excluded if they had a history of major depressive illness, or if they had 
advanced cirrhosis with jaundice, a portocaval shunt, or a prothrombin 
time >19 sec. Other exclusionary criteria included dementia (alcoholic or 
otherwise), aphasia, major stroke, and schizophrenia; current use of med- 
ications known to affect sleep, including centrally acting antihypertensive 
medications, antihistamines, sedatives, hypnotics, stimulants, or other psy- 
weeks at the time of sleep recordings. A total of 189 subjects were 
recruited; however, one woman subject slept for only 55 min during the 
recorded night and was excluded from the analysis. The range of total 
sleep time for the remaining subjects was 153 to 406 min (mean = 307 t 
52 min). The study sample therefore consisted of 188 adult alcoholics (160 
men, 28 women), with an age range of 22 to 76 years. 
One hundred and seventy-eight of the 188 subjects also completed the 
SDQ:4 a standardized instrument used in the assessment of persons with 
suspected sleep disorders in which possible answers are “never,” “rarely,” 
“sometimes,” “usually,” and “always.” The following items were ana- 
lyzed-Q3: I have trouble getting to sleep at night; Q4: I wake up often 
during the night; Q14: My night sleep is restless and disturbed; Q15: At 
night, my sleep disturbs my bed partner’s sleep; Q20: I snore in my sleep; 
Q21: I am told I snore loudly and bother others; Q22: I am told I stop 
breathing (“hold my breath”) in sleep; Q23: I awake suddenly gasping for 
breath, unable to breathe; and Q55: Now, I am very sleepy during the day, 
and I struggle to stay awake. 
Subjects who entered the study before March 1, 1993 completed mul- 
tiple nights of polysomnography, whereas subjects studied after that date 
completed only one night. To ensure that the sample was homogeneous 
with regard to potential first night effects, only data from the first night of 
polysomnography were used for the analyses presented herein. After 
giving informed consent, subjects were studied using standard polysom- 
nographic techniques that recorded the following measures: electroen- 
cephalogram (C3, C4, 01, 0 2  by International 10-20 system), chin elec- 
tromyogram, electrooculogram, electrocardiogram, respiratory effort 
(mercury strain gauges or piezoelectric belts over the chest and abdomen), 
airflow at the nose and mouth (thermistors), and bilateral anterior tibialis 
electromyogram with surface electrodes. Continuous monitoring was per- 
formed by experienced polysomnographic technologists. Oxyhemoglobin 
saturation (SaO,) was monitored by pulse oximetry (Ohmeda Corpora- 
tion, Liberty Corner, NJ). 
All studies were recorded either on paper at 10 mm/sec paper speed 
using polygraphs (Grass Instruments, Quincy, MA), or on paperless com- 
puterized data acquisition systems (Oxford Instruments, Largo, FL, Tele- 
factor Corporation, Conshohocken, PA). No automated scoring was per- 
formed; all recordings were scored manually for sleep stages by 
experienced polysomnographic technologists using standard techniques?6 
Sleep latency was defined in this study as the time from the start of the 
recording (lights out) to the onset of at least 10 continuous min of stage 2, 
3,4, or rapid eye movement (REM) sleep that was interrupted by no more 
than 2 min of stage 1 or 1 min of stage 1 + 1 min of wakefulness. The 
REM sleep latency was defined as the time between sleep onset, as 
defined herein, and the first REM period, minus any intermittent wake- 
fulness during that interval. 
Apneas were defined as absence of airflow for 10 sec or more. Hypop- 
neas were defined as a decrease in respiratory effort with a parallel 
reduction in nasal-oral airflow lasting 10 sec or longer associated with a 
3% or greater drop in oxygen saturation or with an arousal. An AH1 was 
calculated as the number of apneas plus hypopneas per hour of sleep. An 
AI was computed as the number of apneas per hour of sleep. Periodic leg 
movements were scored according to the criteria of C~leman.~’  A periodic 
leg movement index (PLMI) was calculated as the number of periodic leg 
movements occurring during sleep divided by the number of hours of 
sleep. 
We also completed a secondary analysis that compared a subsample of 
the alcoholics to a group of 87 healthy nonalcoholic subjects who had been 
recruited from the community for a study of the effects of low-dose 
alcohol on sleep. The healthy volunteers were screened for probable 
existence of sleep disorders and were excluded from the study if they 
scored above the 70th percentile on any of the four scales of the SDQ. The 
scales have been validated for assessment of narcolepsy, sleep apnea, 
periodic limb movements, and psychiatric causes of sleep dist~rbance.’~ 
To make the comparison groups as similar as possible, the alcoholic 
subsample also included only subjects who scored below the 70th percen- 
tile on all four scales of the SDQ (n = 139). Like the alcoholic sample, the 
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healthy volunteers wcre also scrcened for current and past medical and 
psychiatric conditions through a comprehensive interview that included 
the Diagnostic lntcrview Schedule and werc cxcluded if they had a history 
or currcnt sta:is of significant psychiatric o r  medical illness, including 
major depression, bipolar disorder, dysthymia, anxiety disorder, psychosis, 
posttraumatic strcss disorder. personality disorder. drug or alcohol depen- 
dcncc or  abusc, significant heart discase. scizurc disorder, liver disease, 
gastrointcstinal disease, loss of consciousness, stroke, or transient ischemic 
attack. Thcy were also excluded if they took medications known to affect 
slcep, including ccntrally acting antihypertcnsive mcdications. antihista- 
mines, scdatives. hypnotics, stimulants, or other psychotropic medications. 
Participants werc rcquired to have regular night time sleep habits and 
were excluded if thcy worked rotating shifts or night shifts. A total of 87 
normal subjccts mct these criteria and underwent one night of sleep 
laboratory adaptation, followed by one night of slccp laboratory baseline 
rccording. followcd by one or more nights of alcohol consumption before 
slcep. Only thc night of baseline recording was used for comparison with 
thc subsci of alcoholic subjccts. 
Statistical analysis was performcd using SPSS for Windows (SPSS, Inc., 
Chicago, IL). We used thc AH1 as the primary measurc of apnea severity 
and selccrcd an AH1 of 10 as a cutpoint for defining thc presence of sleep 
apnea. Wc also asscssed another commonly used cutpoint: an AH1 of 5. 
RESULTS 
SDB 
In the sample of 188 alcoholics, a multiple regression 
analysis of age and sex on normalized AHI, while control- 
ling for BMI, was significant (R’ = 0.313, F = 27.9, p < 
0.001) and revealed main effects for all three predictors: 
age (t = 6 . 0 , ~  < 0.001), sex ( t  = 0.55 ,~  = 0.007), and BMI 
( I  = 4 . 8 , ~  < 0.001). 
Twenty-four alcoholic subjects (12.8%) had an AH1 2 
10, and 44 (23.4%) had an AH1 2 5. Of the 160 alcoholic 
men, 24 (15.0%) had an AH1 of 210 eventshr and 43 
(26.9%) had an AH1 2 5. Of the 28 women, none had an 
AH1 z- 10, and 1 had an AH1 2 5.  The gender differences 
in prevalence of SDB were significant for both cutpoints 
(p < 0.001 by Fisher’s exact test). In most subjects with 
SDB. the respiratory events were predominantly obstruc- 
tive. On average, SDB was of moderate severity among the 
subjects with an AH1 2 10, with a mean AH1 of 29.2 and a 
mean minimum Sa02 of 81.3%. 
The proportions of alcoholics with SDB (AH1 2 10) for 
age groups 20 to 29 years (n = 31), 30 to 39 years (n = 60), 
40 to 49 years (n = 68), 50 to 59 years (n = 15), and age 60 
or over ( t i  = 14) are shown in Fig. 1. Of those over age 40 
years, 23.5% had an AH1 2 10, compared with 3.9% of 
those age 40 and under (p < 0.001). Using an AH1 2 5 as 
the cutpoint, the increase in the proportion of subjects over 
age 40 also was highly significant (10.7% for younger alco- 
holics and 38.8% for older alcoholics; p < 0.001). 
We compared polysomnographic features of alcoholic 
subjects with and without SDB using the multivariate Gen- 
eral Linear Model to control for multiple comparisons; the 
results are shown in Table 1. Statistically significant differ- 
ences ( p  < 0.05) included: (1) subjects with AH1 2 10 had 
more stage 1 sleep, less stage 2 sleep, and more PLMs; (2) 
the association with PLMs was age-dependent: the propor- 
Fig. 1. Proportions of alcohdics with SDB. defined by an AH1 2 10. by 
decade. 
tion of alcoholics with PLMI 2 10 was 11.3% overall, 5.8% 
in those age 140, and 16.5% in those age >40 (p = 0.018 
for those 540 vs. those >40); and (3) subjects with AH1 2 
10 had significantly lower time asleep, longer latency to 
continuous sleep, lower sleep efficiency, and shorter REM 
sleep latency. All statistically significant differences re- 
mained significant when men only were analyzed. 
Subjective assessments of sleep also revealed differences 
between alcoholics with SDB, compared with those with- 
out. Those with AH1 2 10 were more likely to report that 
they “never” had trouble getting to sleep at night than 
those with AH1 < 10 (21.7% vs. 6.5%; p < 0.001) and that 
they usually or always felt very sleepy or struggled to stay 
awake during the day (13.0% vs. 3.2%; p < 0.001). With 
AH1 as a continuous variable and age as a covariate, the 
following questionnaire items differed between alcoholics 
with AH1 2 10 and those with AH1 < 10, with apneic 
alcoholics reporting greater frequencies of the symptoms- 
Q15: At night, my sleep disturbs my bed partner’s sleep 
(F = 5 . 1 ; ~  = 0.001); Q22: I am told I stop breathing (“hold 
my breath) in sleep (F = 5.6; p < 0.001); Q55: Now, I am 
very sleepy during the day, and I struggle to stay awake 
To determine whether responses to these SDQ questions 
(Ql5, Q22, and Q55) would help predict the presence of 
SDB in alcoholics, a logistic regression was run with age, 
BMI, and the 3 SDQ questions as predictor variables and 
AH1 > 10 (yes or no) as the response variable. Using only 
age and BMI as predictors, the model correctly classified 
97% of subjects without SDB (AH1 < lo), but only 22% of 
subjects with SDB (AH1 > 10). Adding the SDQ questions 
increased the number of correctly classified subjects with- 
out SDB to 99%, and the number of correctly classified 
with SDB to 43% (R2 = 0 . 5 , ~  C 0.001). 
(F = 12.6;p < 0.001). 
Comparison with Nomal Subjects 
We compared polysomnographic and questionnaire data 
from the alcoholics to a group of normal subjects recruited 
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Table 1. Sleep in 188 Alcoholics With and Without SDB (Mean 2 SD) 
P 
SDB absent SDB present Multivariate 
All subjects (AH1 < 10) (AH1 t 10) GLM 





Years of heavy drinking 
Recording time (min) 
Time awake (min) 
Time asleep (min) 
Sleep latency (min) 
Latency to REM sleep (min) 
Sleep efficiency (%) 
Stage 1 sleep (%) 
Stage 2 sleep (%) 
Stage REM sleep (%) 
Stage 3-4 sleep (%) 
AH I 
Baseline nocturnal SaO, (%) 
Minimum nocturnal SaO, (%) 
% with PLM index >I0 
Age 
I88 
40.8 2 11.1 
160M/28F 
25.8 2 4.5 
85 
22.9 2 19.2 
11.8 2 9.3 
386.8 2 32.8 
79.1 2 46.9 
307.7 2 50.8 
37.5 It 34.3 
71.2 2 51.5 
79.6 2 11.8 
24.1 2 13.7 
47.2 2 12.4 
20.2 2 6.6 
8.5 2 9.3 
5.1 2 13.1 
95.7 t 1.7 
89.3 t 6 
11 
164 
39.3 2 10.1 
136MI28F 
25.3 2 4.1 
84 
21.6 2 18.4 
11.5 2 8.7 
387.6 2 32.6 
74.2 t 45.0 
313.5 t 48.0 
34.2 2 32.6 
75.2 i: 49.9 
81.0 2 11.2 
21.0 2 9.56 
49.7 t 10.1 
20.4 2 6.7 
9.0 2 9.3 
1.5 i: 2.6 
95.8 2 1.7 
90.5 2 4.2 
8 
24 
51.3 t 12.4 
24M 
29.0 2 6.3 
87 
31.5 t 22.6 
13.8 2 12.8 
381.3 t 34.5 
112.6 t 46.7 
268.7 2 52.8 
60.2 2 37.6 
44.0 2 55.3 
70.4 2 11.8 
45.4 t 18.1 
30.7 2 13.6 
18.8 2 6.3 
5.1 2 8.0 
29.2 t 25.7 
95.0 2 1.7 






















GLM, General Linear Model: M, male; F, female; NS, not significant. 
from the community as described in “Methods.” Because 
the responses to the SDQ were used as selection criteria for 
the normal subjects (see “Methods”), we compared the 87 
normal subjects (57 men, 30 women) to only those alcohol- 
ics who also did not score above the 70th percentile on any 
of the SDQ scales. Of the 188 alcoholics, 139 met these 
criteria. 
The SDQ Apnea Scale score is based on the responses to 
12 items that relate to snoring, gasping, witnessed apneas, 
nocturnal sweating, high blood pressure, nasal obstruction, 
body weight, BMI, number of smoking years, and age.24 It 
thus includes the major clinical predictors of OSA.28,29 
Because the SDQ Scale for sleep apnea was one of the 
selection criteria, the exclusion of those persons scoring 
above the 70th percentile on the Apnea Scale means that 
the normal subjects and the subgroup of alcoholics who 
were compared with normal subjects did not have strong 
symptoms or clinical predictors of obstructive sleep apnea 
syndrome. Despite the lack of self-reported symptoms, 
12% of the alcoholics in the subsample (17 of 139 cases) 
had clinically significant SDB on polysomnography, with 
AH1 > 10. Similarly, 12% of controls (10 of 82 subjects for 
whom SDQ scores were available) had clinically significant 
SDB on polysomnography. Because both groups are com- 
prised solely of subjects with normal apnea scale scores, 
sensitivity and specificity of the scale cannot be computed 
from our data. 
In these groups with relatively low likelihood of OSA 
syndrome, we also found that mild SDB (AH1 3 5) was 
more common in the alcoholic subjects than in the controls 
in age-matched subgroups. For example, among subjects 
over age 55, the proportion with AH1 2 5 was 67% for the 
alcoholics and 31% for the controls (p  = 0.026 by Fisher’s 
exact test). Among subjects over the age of 40, the propor- 
tion with AH1 L 5 was 41% for the alcoholics and 23% for 
the controls (p = 0.035). Among subjects < age 55, the 
proportion with AH1 2 5 was 19% for the alcoholics and 
7% for the controls (p = 0.029), whereas among subjects < 
age 40, the proportion with AH1 L 5 was 11% for the 
alcoholics and 0% for the controls (p = 0.046). Thus, 
among alcoholics and normal subjects matched for the 
relative absence of sleep-related symptoms, alcoholics of all 
ages were more likely to have mild SDB. In addition, 
nocturnal hypoxemia was more pronounced in the alco- 
holic group, with a lower baseline nocturnal SaOz (p < 
0.001) and a lower minimum Sa02 (p < 0.001) (Table 2). 
Furthermore, we found a significant interaction between 
group (alcoholics vs. nonalcoholics) and age for the AH1 
(F = 8 . 6 7 ; ~  < 0.001). 
We also assessed sleep architecture in the normal sub- 
jects and the group of 139 alcoholics meeting the SDQ 
criteria (Table 2). In this comparison, alcoholics had less 
sleep time (p < 0.001), lower sleep efficiency (p = 0.009), 
more stage 1 sleep (p = 0.009), and less delta sleep (p = 
0.007). Differences in sleep architecture were more pro- 
nounced in younger subjects than in older subjects. Among 
subjects age 40 or less, alcoholics had less sleep (p < 
0.001), more time awake Cp = 0.003), longer sleep latency 
(p = 0.044), lower sleep efficiency (p = 0.001), more stage 
1 sleep (p = 0.001), and less delta sleep (p = 0.029). On the 
other hand, the only significant difference among subjects 
over age 40 was a reduction in sleep time among alcoholics 
(p = 0.016). 
DISCUSSION 
We found SDB, primarily obstructive, in a substantial pro- 
portion of alcoholics, with a strong association with age. Al- 
coholics with SDB were more likely to be men and had more 
sleep disruption, more complaints of daytime sleepiness, and 
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Normal subjects GLM 






Years of heavy drinking 
Recording time (min) 
Time awake (min) 
Time asleep (min) 
Sleep latency (min) 
Latency to REM sleep (min) 
Sleep efficiency (%) 
Stage 1 sleep (%) 
Stage 2 sleep (%) 
Stage REM sleep (%) 
Stage 3-4 sleep (%) 
AH1 
Baseline SaO, (%) 
Minimum SaO, (%) 
% with PLM index >lo 
139 
40.7 ir 11.4 
11 8M121 F 
25.6 ir 4.2 
83% 
21.2 2 18.8 
11.7 2 9.7 
386.9 ir 33.2 
77.2 t 46.5 
35.6 2 33.2 
76.1 -C 54.0 
24.1 ir 14.1 
47.9 t 12.6 
20.1 2 6.5 
309.7 ir 50.8 
80.1 2 11.7 
8.0 -t 8.8 
4.6 ? 11.5 
95.7 ir 1.7 
89.5 ir 5.6 
10.6% 
a7 
25.3 2 4.1 
47.1 2 14.6 
57M130F 
2.3% 
0.3 2 2.1 
0 
65.3 ? 52.6 
343.4 2 55.9 
72.9 2 43.4 
408.7 2 29.3 
28.2 2 35.2 
84.1 2 12.7 
18.9 ir 15.1 
50.4 ir 12.8 
19.3 2 6.1 
11.4 ir 10.1 
97.4 ir 1.4 
94.6 t 6.8 






















GLM. General Linear Model; M, male; F, female: NS. not significant. 
more hypoxemia than alcoholics without SDB. The severity of 
SDB, as defined by the AHI, was a function of age and BMI. 
When these two factors were controlled for, severity of SDB 
was not significantly affected by smoking history or by the 
duration of heavy drinking. In a comparison of alcoholics and 
normal subjects who were matched for a relative absence of 
sleep complaints, alcoholics of all age groups were more likely 
to have mild SDB. They also had more nocturnal hypoxemia 
and greater degrees of sleep disruption. These findings indi- 
cate that: ( I )  SDB is common among alcoholics, especially 
older alcoholics; (2) SDB in alcoholics is associated with 
significant effects on nocturnal oxygenation; and (3) SDB is a 
substantial contributor to daytime sleep-related symptoms in 
alcoholics. 
As described in “Methods,” some of the alcoholics in our 
sample had multiple nights of polysomnography and some 
had only one. To ensure that data for the full sample were 
homogeneous, only the first night measurements for all 
subjects were analyzed. This raises the question of whether 
one night is sufficient for assessment of SDB. Characteris- 
tics of sleep in a sleep laboratory differ on the first night of 
sleep when compared with subsequent nights. The “first- 
night effects” include increased sleep latency, increased 
REM sleep latency, and reduced amounts of REM sleep. 
However, the first-night effects on breathing appear to be 
much less. Dickel and Mosko” found no first-night effect 
on the frequency of respiratory events in 100 seniors eval- 
uated for sleep apnea and periodic leg movements. Bliwise 
and associates” found that measures of disordered breath- 
ing were fairly stable across two nights, although there was 
an mild increase in some subjects on the second night. 
Thus, whereas night-to-night variability in severity of SDB 
occurs in individuals, current evidence suggests that one 
night of study is sufficient to characterize SDB in groups of 
research subjects. 
The increase in SDB with age confirms our earlier find- 
i n g ~ , ~ ~  and the association of polysomnographically con- 
firmed SDB with symptoms of poor sleep and daytime 
sleepiness suggests that our data are clinically relevant. 
That SDB increases with age in alcoholics is not surprising, 
because its prevalence increases with age in the general 
p~pulation.~’ However, whereas SDB is common among 
the elderly, a wide range of prevalence rates have been 
reported (see B l i ~ i s e ~ ~  for review). Differences in reported 
prevalence rates probably reflect differences in recruitment 
methods and differences in definitions of SDB. 
Because our group of normal subjects was not represen- 
tative of the general population, our data do not allow us to 
determine whether sleep apnea is more prevalent among 
alcoholics than among the general population for various 
age groups. However, our results do suggest that the prev- 
alence of SDB is not markedly increased in middle-aged 
alcoholics, compared with the general population. For ex- 
ample, the prevalence of SDB (defined as AH1 2 10) in 
alcoholic men between the ages of 40 and 60 in this study 
(18% for ages 40 to 49 and 25% for ages 50 to 59) is only 
modestly higher than the prevalence of 14% and 18% for 
these age groups reported by Young et al.’l in a study of 
men from Wisconsin. In our study, 1 of 28 women alcohol- 
ics (3.6%) had SDB, a prevalence similar to the 5% for 
middle-aged women in the study by Young et al. 
Daytime sleepiness, a major complaint in most persons 
with SDB, is caused at least in part by sleep fragmentation 
associated with resumption of breathing. In alcoholics with 
SDB, evening alcohol use is likely to increase the frequency 
and severity of obstructive apneas, leading to greater sleep 
disruption and more pronounced daytime effects. Further- 
more, sleepiness caused by sleep disruption or other factors 
associated with SDB may add to sedative effects of alcohol 
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to produce greater impairments of daytime alertness and 
cognitive function. 
The greater severity of hypoxemia in association with SDB 
in alcoholic subjects, compared with nonalcoholic subjects, 
may have important clinical implications. The high rate of 
cigarette smoking in the alcoholic group, combined with SDB, 
probably accounts for the more severe hypoxemia. Our stud- 
ies were performed in abstinent alcoholics; it is highly likely 
that hypoxemia is more severe in actively drinking alcoholics, 
because alcohol use tends to increase apnea duration and 
increase the severity of associated hypoxemia. 
In addition to hypoxemia, obstructive apneas are often 
accompanied by reductions of cardiac output due to right 
to left shifts of the cardiac interventricular septum. Hypox- 
emia and acidosis may lead to increased pulmonary and 
systemic arterial blood pressure, despite the fall in cardiac 
output, whereas increased vagal tone and hypoxemia con- 
tribute to cardiac arrhythmias. Increased sympathetic ner- 
vous system activity during the arousals that accompany the 
end of apneas contributes to increased blood pressure and 
to the potential for dangerous ventricular tachyarrhyth- 
mias. SDB may contribute to daytime systemic hyperten- 
sion in some patients as a result of hypoxemia or altered 
sympathetic activity.28 Because alcohol also may lead to 
increased ventricular ectopy,"334 alcoholics with SDB who 
are actively drinking are likely to be at increased risk for 
suspected cardiovascular complications of SDB, including 
stroke, myocardial infarction, and sudden death.'"-'"3"'-'" 
Thus, SDB, when combined with existing cardiovascular 
risk factors and alcohol use, may be a significant factor in 
the increased risk of stroke and mortality that occurs in 
alcohol users.4024' 
Our findings suggest that SDB is common in alcoholics 
and that it may contribute to poor treatment outcome and 
increased risk of stroke, myocardial infarction, and sudden 
death in these patients. Impairments in daytime function- 
ing commonly associated with SDB, including decreased 
alertness and impaired cognitive function, may affect alco- 
hol treatment response. In addition, alcoholics who are 
actively drinking are likely to experience a higher frequency 
of obstructive apneas and more severe hypoxemia, which 
can lead to greater sleep disruption and more pronounced 
daytime effects. Clinical evaluation of sleep-related com- 
plaints and treatment of SDB may help decrease the inci- 
dence of cardiovascular morbidity and mortality, and may 
help improve the response to alcohol treatment. 
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